Kirk D. Miller

3.7k citations

34 papers · 2.7k indexed · 2 hit papers · h-index 22

Impact in

Virology top 0.5%
- HIV Research and Treatment
Emergency Medicine top 0.5%
- HIV-related health complications and treatments

Papers in

Virology 10
- HIV Research and Treatment 8
Infectious Diseases 14
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 4

Co-authors: Jack A. Yanovski Elizabeth C. Jones Irwin M. Feuerstein J Falloon Carlos C. Campbell Richard T. Davey Judith Falloon Henry Masur
Journals: The Journal of Infectious Diseases (6 papers)American Journal of Tropical Medicine and Hygiene (4 papers)Clinical Infectious Diseases (3 papers)New England Journal of Medicine (3 papers)The Lancet (3 papers)
Partner nations: United States Thailand Belgium

In The Last Decade

Kirk D. Miller

33 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression 1999 · 639 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Proceedings of the National Academy of Sciences
1998 The Lancet

Peers

Countries citing papers authored by Kirk D. Miller

Since Specialization

Citations

This map shows the geographic impact of Kirk D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk D. Miller more than expected).

Fields of papers citing papers by Kirk D. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk D. Miller. The network helps show where Kirk D. Miller may publish in the future.

Co-authors

The 25 scholars most cited alongside Kirk D. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk D. Miller Line = papers co-authored together Kirk D. Miller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Increases in CD4+ T Lymphocytes Occur Without Increases in Thymic Size in HIV-Infected Subjects Receiving Interleukin-2 Therapy JAIDS Journal of Acquired Immune Deficiency Syndromes ·Amy C. Lu, Elizabeth C. Jones, Catherine Chow, Kirk D. Miller, Betsey Herpin, Diane Rock-Kress, Julia A. Metcalf, H. Clifford Lane, Joseph A. Kovacs	2003	5
2	Urinary Cytology Associated With Human Polyomavirus and Indinavir Therapy in HIV-Infected Patients American Journal of Clinical Pathology ·Armando Filie, Anna Maria Wilder, Keith Brosky, Jeffrey B. Kopp, Kirk D. Miller, Andrea Abati	2002	2
3	Indinavir‐Associated Interstitial Nephritis and Urothelial Inflammation: Clinical and Cytologic Findings Clinical Infectious Diseases ·Jeffrey B. Kopp, Judith Falloon, Armando Filie, Andrea Abati, Christine King, Glen L. Hortin, JoAnn M. Mican, Ellen M. Vaughan, Kirk D. Miller	2002	37
4	Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion Clinical Immunology ·Kirk D. Miller, Katherine Spooner, Betsey Herpin, Diane Rock-Kress, Julia A. Metcalf, Richard T. Davey, Judith Falloon, Joseph A. Kovacs, Michael A. Polis, Robert Walker, Henry Masur, H. Clifford Lane	2001	16
5	Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy AIDS ·Hiroyu Hatano, Kirk D. Miller, Christian Yoder, Jack A. Yanovski, Nancy G. Sebring, Elizabeth C. Jones, Richard T. Davey	2000	51
6	Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy The Journal of Clinical Endocrinology & Metabolism ·Jack A. Yanovski, Kirk D. Miller, Tomoshige Kino, Theodore C. Friedman, George P. Chrousos, Constantine Tsigos, Judith Falloon	1999	122
7	Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus‐Infected Patients: Protease Inhibitors, Non‐Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase Inhibitors Clinical Infectious Diseases ·Jorge A. Tavel, Kirk D. Miller, Henry Masur	1999	34
8	Hepatitis G Virus and Human Immunodeficiency Virus Coinfection: Response to Interferon‐α Therapy The Journal of Infectious Diseases ·Daryl Lau, Kirk D. Miller, Jill Detmer, Janice A. Kolberg, Betsey Herpin, Julia A. Metcalf, Richard T. Davey, Jay H. Hoofnagle	1999	29
9	Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient AIDS ·Jan M. Orenstein, Mark B. Feinberg, Christian Yoder, Lewis K. Schrager, JoAnn M. Mican, Douglas J. Schwartzentruber, Richard T. Davey, Robert Walker, J Falloon, Joseph A. Kovacs, Kirk D. Miller, Cecil H. Fox, Julia A. Metcalf, Henry Masur, Michael A. Polis	1999	62
10	Visceral abdominal-fat accumulation associated with use of indinavir The Lancet ·Kirk D. Miller, Elizabeth C. Jones, Jack A. Yanovski, Rani Shankar, Irwin M. Feuerstein, J Falloon Hit paper breakdown →	1998	558
11	Asymptomatic Solitary Pulmonary Nodules Due to Cryptococcus neoformans in Patients Infected with Human Immunodeficiency Virus Clinical Infectious Diseases ·Kirk D. Miller, Jo Ann M. Mican, Richard T. Davey	1996	22
12	Biochemical Evidence of Muscle Injury in African Children with Severe Malaria The Journal of Infectious Diseases ·Kirk D. Miller, Nicholas J. White, (unknown), J. Murray Roberts, B. M. Greenwood	1989	39
13	Treatment of Severe Malaria in the United States with a Continuous Infusion of Quinidine Gluconate and Exchange Transfusion New England Journal of Medicine ·Kirk D. Miller, AlanE. Greenberg, Carlos C. Campbell	1989	115
14	Chloroqine Treatment of Severe Malaria in Children New England Journal of Medicine ·Nicholas J. White, Kirk D. Miller, Frederick C. Churchill, C. Berry, Judith Brown, S B Williams, Brian Greenwood	1988	88
15	Early Acquisition of Antibody to Plasmodium falciparum Sporozoites in Nonimmune Temporary Residents of Africa The Journal of Infectious Diseases ·Kirk D. Miller, Gary H. Campbell, Thomas B. Nutman, M Mulligan, Bart J. Currie, P M Procell, J. Murray Roberts	1988	6
16	Diethylcarbamazine Prophylaxis for Human Loiasis New England Journal of Medicine ·Thomas B. Nutman, Kirk D. Miller, Maurita Mulligan, G. Reinhardt, Bart J. Currie, Cathy Steel, Eric A. Ottesen	1988	29
17	HYPOGLYCAEMIA IN AFRICAN CHILDREN WITH SEVERE MALARIA The Lancet ·Nicholas J. White, Kevin Marsh, R. C. Turner, Kirk D. Miller, C. Berry, D H Williamson, Judith Brown	1987	176
18	Continuous-Infusion Quinidine Gluconate for Treating Children with Severe Plasmodium falciparum Malaria The Journal of Infectious Diseases ·Gail Rudnitsky, Kirk D. Miller, Tiago Costa de Pádua, T L Stull	1987	9
19	Severe Cutaneous Reactions among American Travelers Using Pyrimethamine-Sulfadoxine (Fansidar®) for Malaria Prophylaxis American Journal of Tropical Medicine and Hygiene ·Kirk D. Miller, Hans O. Lobel, Richard F. Satriale, Joel N. Kuritsky, Robert S. Stern, Carlos C. Campbell	1986	157
20	In vivo chloroquine-resistant falciparum malaria in western Africa. PubMed ·Janet Neequaye, J Coene, H Taelman, M Wéry, AlanE. Greenberg, Garold Minns, Leslie C. Patchen, Kirk D. Miller	1986	46

About Kirk D. Miller

Kirk D. Miller is a scholar working on Virology, Infectious Diseases, Hepatology, Emergency Medicine and Public Health, Environmental and Occupational Health, having authored 34 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Malaria Research and Control (8 papers), HIV/AIDS drug development and treatment (8 papers), Mosquito-borne diseases and control (7 papers), HIV-related health complications and treatments (6 papers), Hepatitis C virus research (5 papers), HIV/AIDS Research and Interventions (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Virology (1.3k citations), Emergency Medicine (757 citations), Infectious Diseases (1.3k citations), Public Health, Environmental and Occupational Health (608 citations) and Parasitology (135 citations). Kirk D. Miller has collaborated with scholars based in United States, Thailand and Belgium. Frequent co-authors include Jack A. Yanovski, Elizabeth C. Jones, Irwin M. Feuerstein, J Falloon, Carlos C. Campbell, Richard T. Davey, Judith Falloon, Henry Masur, AlanE. Greenberg and Nicholas J. White. Their work appears in journals such as The Journal of Infectious Diseases, American Journal of Tropical Medicine and Hygiene, Clinical Infectious Diseases, New England Journal of Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact